• Snoop Dogg's weed media company launches new ad agency with ex-Vice execs

    28 days ago - By Fast Company

    Gram x Gram is a cannabis-specific ad and branding agency aiming to both build weed brands and help mainstream marketers tap into the cannabis market.
    A decade ago, Vice was getting so many requests from brands on how to more effectively market to the media company's young audience that it officially launched its own creative agency called Virtue. CEO Shane Smith said at the time , “Our whole modus operandi was not to bullshit. We decided to set up this separate wing that could leverage our talent but also be a separate company to help brands reach this demographic.”
    Read more ...

     

  • New Coke returns with Stranger Things: Here's how to get your limited-edition can

    28 days ago - By Fast Company

    Coca-Cola's failed experiment is back thanks to Netflix's hit TV show.
    On April 23, 1985, The Coca-Cola Company launched a big experiment. The storied soda company announced that it was changing the formula for the world's most popular soft drink for the first time in 99 years. The company's big gamble did not pay off.
    Read more ...

     

  • The US just warned that drones made in China could be used as a way to spy, but not in the way you think

    The US just warned that drones made in China could be used as a way to spy, but not in the way you think

    28 days ago - By Business Insider

    The US Department of Homeland Security is concerned that China-made drones and the data they can collect could potentially get into the hands of the Chinese government , according to a DHS alert obtained by CNN .
    No manufacturer is singled out in the alert, but industry analysis claims that Chinese drone manufacturer DJI holds up to 80% of the drone market share in North America.
    The DHS alert comes a week after President Donald Trump banned the sale of Huawei telecoms equipment in the US.
    Visit Business Insider's homepage for more stories.
    The US Department of Homeland Security is...
    Read more ...

     

  • A top exec at GlaxoSmithKline gave us an inside look at the $100 billion pharma giant's experiment with a new way of getting paid for medicines

    A top exec at GlaxoSmithKline gave us an inside look at the $100 billion pharma giant's experiment with a new way of getting paid for medicines

    28 days ago - By Business Insider

    Pharma companies need to move to new ways of getting paid for their products, said Jack Bailey , president of US pharmaceuticals for the $100 billion British drugmaker GlaxoSmithKline.
    GlaxoSmithKline has been experimenting with a new approach for three to four years. Called value-based care , it means that instead of getting paid per pill, GSK gets paid based on how well those pills work.
    Bailey gave us an inside look at the programs and what he's learned from the experience. Read on for more.
    Visit Business Insider's homepage for more stories.
    Change is afoot in the US healthcare...
    Read more ...